Simcere Pharmaceutical: Net profit in 2025 is expected to increase by approximately 80.1% to 93.9% year-over-year
Simcere Pharmaceutical (02096.HK) announced that, The Group expects to record revenue of approximately RMB7.7 billion to RMB7.8 billion for the fiscal year 2025, representing an increase of approximately 16.0% to 17.6% compared to the revenue of approximately RMB6.635 billion for the year ended December 31, 2024. The Group is expected to record profit attributable to equity holders of the Company of approximately RMB 1.3 billion to RMB 1.4 billion for the fiscal year 2025, representing an increase of approximately 80.1% to 93.9% compared to the restated profit attributable to equity holders of the Company of approximately RMB 722 million for the fiscal year 2024.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Source:富途快讯 · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
UNI Price Dynamics: Breaking Key Resistance, Can $8 Be the Next Target?
-
2
US Retail Sales Rise 1.2% in August, Beating Estimates After July Drop
-
3
DOGE and Blockchain Gaming: Exploring Emerging Economic Models
-
4
Lookonchain: A newly created wallet bought 99,834 HYPE tokens worth $7.72 million via FalconX
-
5
Yahoo Finance Analysis: SpaceX's AI cloud leasing business is growing rapidly, potentially boosting its valuation from $2 trillion to $3 trillion.
-
6
Former Infosys CEO's AI startup Hang Ten Systems nabs another $53M, bringing total funding to $85M
-
7
Winbond Electronics to Acquire Infineon's NOR Flash and F-RAM Businesses for $1.12 Billion in Cash
-
8
Talenthon (TCOIN) Project Analysis: ICO Project Status in 2018 and Differentiation of Same-Name Tokens
-
9
SoftBank Group's record $6.45 billion retail bond sale on Thursday will boost its share of Japan's corporate retail bond market to nearly 50%
-
10
Experts at Fashion Tech Show suggest AI and automation are key to overcoming onshoring challenges
Markets Today
Recommended Reading





